Endothelial cell tropism in the pathogenesis and host response against influenza viruses - Resubmission 01
流感病毒发病机制和宿主反应中的内皮细胞向性 - 重新提交 01
基本信息
- 批准号:10303023
- 负责人:
- 金额:$ 54.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-12-08 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Respiratory Distress SyndromeAdultAntiviral ResponseAttenuated VaccinesAvian Influenza A VirusBiological ModelsBlood VesselsCell Adhesion MoleculesCellsCharacteristicsCoculture TechniquesDevelopmentDiseaseDisease ProgressionDown-RegulationElderlyEndothelial CellsEndotheliumEngineeringEpidemicEpithelial CellsExtravasationFerretsGenerationsGoalsHealthHematopoieticHumanImmuneImmune responseImmunocompromised HostIndividualInfectionInflammatoryInflammatory ResponseInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H5N1 SubtypeInfluenza A Virus, H7N7 SubtypeInfluenza A Virus, H7N9 SubtypeInfluenza A virusInjuryInnate Immune ResponseIntegration Host FactorsKnowledgeLinkLower respiratory tract structureLungMediatingMicroRNAsModelingMolecularMorbidity - disease rateMusNatureNeutrophil InfiltrationNosePathogenesisPathogenicityPositioning AttributePredispositionProductionPulmonary EdemaReporterReportingResearch PersonnelRoleSeverity of illnessSiteSurvival RateSymptomsTestingTherapeuticTransgenic OrganismsTropismUpper Respiratory InfectionsVascular PermeabilitiesViralViral GenesViral GenomeViral Load resultViral PathogenesisViral PneumoniaVirulenceVirulentVirusVirus DiseasesVirus ReplicationVulnerable Populationsage groupburden of illnesscell typecytokineexperimental studyimmunopathologyimprovedin vivoinfluenza infectioninfluenza virus straininfluenzaviruslung injurymembermonocytemortalitymouse modelneutrophilnovelnovel therapeutic interventionpandemic diseasepathogenpreventrational designrecombinant virusrecruitseasonal influenzatissue tropismtool
项目摘要
ABSTRACT
Influenza A viruses pose a serious threat to human health, causing seasonal epidemics and occasional
pandemics that result in significant morbidity and mortality worldwide. The virulence and pathogenic nature of
influenza virus strains vary greatly, and is often determined by the constellation of viral genes. While seasonal
influenza viruses cause a mild upper respiratory infection in healthy individuals, highly pathogenic avian
influenza viruses (HPAIV) of the H5N1 subtype replicate in the lower respiratory tract, causing fatal viral
pneumonia characterized by pulmonary edema and vascular leakage. In addition, H5N1 infections are
associated with an uncontrolled activation of host immune responses, which contributes to the severity of
disease. The role of viral and host factors in the enhanced virulence and pulmonary immunopathology
characteristic of HPAIV infections remain unknown. To this end, we engineered H5N1 viruses with restricted
tropism through the incorporation of microRNA (miRNA) target sites into the viral genome. Specifically, we
generated an H5N1 virus carrying endothelial cell specific miR-126 target sites (H5N1-126T), such that viral
replication was abrogated in endothelial cells without impeding replication in other cell types. In our recent
studies, H5N1-126T infected mice and ferrets showed significantly reduced virulence and vascular leakage in
the lungs as compared to the control H5N1-ScrbT virus infected group, despite similar viral loads in the lungs
of mice and nasal washes of ferrets. To our knowledge, this is the first study to demonstrate the importance of
endothelial cell tropism to H5N1 pathogenesis. The current proposal will (1) determine the consequence of
endothelial cell infection to barrier integrity and function, (2) investigate the role of endothelial cell tropism in
orchestrating immune responses, and (3) assess the contribution of viral tropism to the pathogenesis of other
highly virulent strains including H7N7, 1918 H1N1, and H7N9 in mice and ferrets. The knowledge gained from
these studies will help to elucidate the mechanism by which virulent influenza viruses cause severe disease
and aid in the development of novel therapeutic strategies against virulent influenza strains. Furthermore,
these studies will reveal how viral tropism modulates host antiviral responses and will pave the way for the
rational design of novel live attenuated vaccines with restricted tropism.
抽象的
流感病毒对人类健康构成严重威胁,引起季节性流行病和偶尔
大流行病导致全球发病率和死亡率很大。毒力和致病性
流感病毒菌株变化很大,通常由病毒基因的星座确定。季节性
流感病毒在健康个体中引起轻度的上呼吸道感染,高度致病的鸟类
H5N1亚型在下呼吸道中复制的流感病毒(HPAIV),导致致命病毒
肺炎的特征是肺水肿和血管渗漏。另外,H5N1感染是
与宿主免疫反应的不受控制的激活相关,这有助于
疾病。病毒和宿主因素在增强的毒力和肺部免疫病理学中的作用
HPAIV感染的特征仍然未知。为此,我们对H5N1病毒进行了限制
通过将microRNA(miRNA)靶位点掺入病毒基因组中的向热力主义。具体来说,我们
产生了携带内皮细胞特异性miR-126靶位点(H5N1-126T)的H5N1病毒,以便病毒
在内皮细胞中废除了复制,而不会阻碍其他细胞类型的复制。在我们最近的
研究,H5N1-126T感染的小鼠和雪貂在毒力和血管泄漏显着降低
与对照H5N1-SCRBT病毒感染组相比,肺部尽管肺部有相似的病毒负荷
雪貂的小鼠和鼻腔洗涤。据我们所知,这是第一项证明重要性的研究
H5N1发病机理的内皮细胞向量。当前的提案将(1)确定
内皮细胞感染对屏障完整性和功能,(2)研究内皮细胞偏向主义在
策划免疫反应,(3)评估病毒tropism对其他发病机理的贡献
小鼠和雪貂中的高毒素包括H7N7,1918 H1N1和H7N9。从中获得的知识
这些研究将有助于阐明毒性流感病毒引起严重疾病的机制
并有助于开发针对有毒流感菌株的新型治疗策略。此外,
这些研究将揭示病毒性向往往如何调节宿主抗病毒反应,并为
新颖的活衰减疫苗的理性设计与恐怖症。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication.
- DOI:10.1016/j.celrep.2018.03.045
- 发表时间:2018-04-10
- 期刊:
- 影响因子:8.8
- 作者:Han J;Perez JT;Chen C;Li Y;Benitez A;Kandasamy M;Lee Y;Andrade J;tenOever B;Manicassamy B
- 通讯作者:Manicassamy B
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics.
针对流感病毒的广泛保护策略:通用疫苗和治疗方法。
- DOI:10.3389/fmicb.2020.00135
- 发表时间:2020
- 期刊:
- 影响因子:5.2
- 作者:Vogel,OliviaA;Manicassamy,Balaji
- 通讯作者:Manicassamy,Balaji
Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.
- DOI:10.1128/jvi.01837-21
- 发表时间:2022-02-09
- 期刊:
- 影响因子:5.4
- 作者:Malicoat J;Manivasagam S;Zuñiga S;Sola I;McCabe D;Rong L;Perlman S;Enjuanes L;Manicassamy B
- 通讯作者:Manicassamy B
Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species.
- DOI:10.1371/journal.ppat.1006270
- 发表时间:2017-03
- 期刊:
- 影响因子:6.7
- 作者:Tundup S;Kandasamy M;Perez JT;Mena N;Steel J;Nagy T;Albrecht RA;Manicassamy B
- 通讯作者:Manicassamy B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Balaji Manicassamy其他文献
Balaji Manicassamy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Balaji Manicassamy', 18)}}的其他基金
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
DNA 结合转录抑制复合物 CIC-ATXN1/L 对先天抗病毒反应的调节
- 批准号:
10874145 - 财政年份:2022
- 资助金额:
$ 54.03万 - 项目类别:
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
DNA 结合转录抑制复合物 CIC-ATXN1/L 对先天抗病毒反应的调节
- 批准号:
10671677 - 财政年份:2022
- 资助金额:
$ 54.03万 - 项目类别:
Regulation of innate antiviral responses by the DNA-binding transcriptional repressor complex CIC-ATXN1/L
DNA 结合转录抑制复合物 CIC-ATXN1/L 对先天抗病毒反应的调节
- 批准号:
10539709 - 财政年份:2022
- 资助金额:
$ 54.03万 - 项目类别:
ENDOTHELIAL CELL TROPISM IN THE PATHOGENESIS AND HOST RESPONSE AGAINST INFLUENZA VIRUSES - RESUBMISSION 01
发病机制中的内皮细胞趋向性和宿主对流感病毒的反应 - 重新提交 01
- 批准号:
9769437 - 财政年份:2017
- 资助金额:
$ 54.03万 - 项目类别:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
- 批准号:
9083899 - 财政年份:2016
- 资助金额:
$ 54.03万 - 项目类别:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
- 批准号:
9472173 - 财政年份:2016
- 资助金额:
$ 54.03万 - 项目类别:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
- 批准号:
9925203 - 财政年份:2016
- 资助金额:
$ 54.03万 - 项目类别:
Pan-Influenza virus inhibitors: Small molecules that disrupt host ADAR1-viral NS1 interactions
泛流感病毒抑制剂:破坏宿主 ADAR1-病毒 NS1 相互作用的小分子
- 批准号:
9086232 - 财政年份:2015
- 资助金额:
$ 54.03万 - 项目类别:
Pan-Influenza virus inhibitors: Small molecules that disrupt host ADAR1-viral NS1 interactions
泛流感病毒抑制剂:破坏宿主 ADAR1-病毒 NS1 相互作用的小分子
- 批准号:
8956083 - 财政年份:2015
- 资助金额:
$ 54.03万 - 项目类别:
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
腺苷脱氨酶对流感病毒复制和适应性的调节
- 批准号:
9090008 - 财政年份:2015
- 资助金额:
$ 54.03万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Treatment of Inflammatory Complications of Viral Pneumonia
病毒性肺炎炎症并发症的治疗
- 批准号:
10383991 - 财政年份:2022
- 资助金额:
$ 54.03万 - 项目类别:
Profiling the immune response to convalescent plasma therapy during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
分析严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染期间恢复期血浆治疗的免疫反应
- 批准号:
10373738 - 财政年份:2022
- 资助金额:
$ 54.03万 - 项目类别:
Profiling the immune response to convalescent plasma therapy during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
分析严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染期间恢复期血浆治疗的免疫反应
- 批准号:
10609455 - 财政年份:2022
- 资助金额:
$ 54.03万 - 项目类别:
COVID-19: HDL's Role in Innate Immunity and Cardiovascular Protection with COVID-19
COVID-19:HDL 在 COVID-19 的先天免疫和心血管保护中的作用
- 批准号:
10153344 - 财政年份:2021
- 资助金额:
$ 54.03万 - 项目类别:
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
针对 COVID-19 和未来大流行病的 Minibinder 拮抗剂的从头设计
- 批准号:
10296596 - 财政年份:2021
- 资助金额:
$ 54.03万 - 项目类别: